Molecular identification of Fusarium species complex isolated from clinical samples and its antifungal susceptibility patterns

Publish Year: 1398
نوع سند: مقاله ژورنالی
زبان: English
View: 75

This Paper With 7 Page And PDF Format Ready To Download

  • Certificate
  • من نویسنده این مقاله هستم

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این Paper:

شناسه ملی سند علمی:

JR_CUMM-5-4_007

تاریخ نمایه سازی: 11 آذر 1402

Abstract:

Background and Purpose: More than ۳۰۰ Fusarium species are grouped into approximately ۲۳ species complexes out of which around ۷۰ are involved in human infections. The nomenclature of these species has undergone considerable changes in recent years. These species cause localized infections in individuals while inducing systemic infections mainly in immunocompromised patients. The present study was conducted to identify Fusarium species in clinical isolates by molecular methods and determine their in vitro minimum inhibitory concentration (MIC) patterns to address the lack of data in this domain in Northern India. Materials and Methods: For the purpose of the study, Fusarium isolates obtained from various clinical samples were sent to the Westerdijk Fungal Biodiversity Institute, Utrecht, the Netherlands, for molecular identification. The MIC testing was performed using the microbroth dilution method as per the Clinical and Laboratory Standards Institute reference method (M۳۸-A۲). Results: Fusarium was isolated from ۳۳ patients (i.e., ۱, ۱, ۲, ۱۴, and ۱۵ cases with endophthalmitis, sinusitis, pulmonary involvement, onychomycosis, and keratitis, respectively). These ۳۳ isolates belonged to three species complexes, namely F. solani species complex (FSSC; n=۱۳), F. fujikuroi species complex (FFSC; n=۱۳), and F. incarnatum equiseti species complex (FIESC; n=۷). The species identified within FSSC, FFSC, and FIESC included F. keratoplasticum (n=۶)/F. falciforme (n=۶)/F. solani (n=۱), F. proliferatum (n=۷)/F. sacchari (n=۵)/F. anthophilum (n=۱), and F. incarnatum SC species (n=۶)/F. equiseti SC species (n=۱), respectively. The MIC results showed that all isolates had a lower MIC against amphotericin B than against the other antifungal agents. Conclusion: Timely diagnosis and appropriate treatment will facilitate the improvement of patient outcomes.

Authors

Yashik Bansal

Department of Microbiology, Government Medical College Hospital, Chandigarh, India

Nidhi Singla

Department of Microbiology, Government Medical College Hospital, Chandigarh, India

Neelam Kaistha

Department of Microbiology, Government Medical College Hospital, Chandigarh, India

Sunandan Sood

Department of Ophthalmology, Government Medical College Hospital, Chandigarh, India

Jagdish Chander

Department of Microbiology, Government Medical College Hospital, Chandigarh, India

مراجع و منابع این Paper:

لیست زیر مراجع و منابع استفاده شده در این Paper را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود Paper لینک شده اند :
  • Costa-Orlandi CB, Sardi JCO, Pitangui NS, de Oliveira HC, Scorzoni ...
  • Nucci M, Anaissie EJ. Fusarium infections in immune-compromised patients. Clin ...
  • Tupaki-Sreepurna A, Kindo AJ. Fusarium: the versatile pathogen. Indian J ...
  • Moretti ML, Busso-Lopes AF, Tararam CA, Moraes R, Muraosa Y, ...
  • Chilaka CA, De Boevre M, Atanda OO, De Saeger S. ...
  • Jacobs-Venter A, Laraba I, Geiser DM, Busman M, Vaughan MM, ...
  • Guarro J. Fusariosis, a complex infection caused by a high ...
  • Douglas AP, Chen SC, Slavin MA. Emerging infections caused by ...
  • Harpaz R, Dahl RM, Dooling KL. Prevalence of immunosuppression among ...
  • Nucci M, Varon AG, Garnica M, Akiti T, Barreiros G, ...
  • Schroers HJ, Gräfenhan T, Nirenberg HI, Seifert KA. A revision ...
  • Gräfenhan T, Schroers HJ, Nirenberg HI, Seifert KA. An overview ...
  • Hawksworth D. A new dawn for the naming of fungi: ...
  • Hawksworth DL, May TW, Redhead SA. Fungal nomenclature evolving: changes ...
  • Abastabar M, Al-Hatmi AMS, Vafaei Moghaddam M, de Hoog GS, ...
  • van Diepeningen AD, Brankovics B, Iltes J, van der Lee ...
  • Al-Hatmi AMS, Curfs-Breuker I, de Hoog GS, Meis JF, Verweij ...
  • Al-Hatmi AM, Hagen F, Menken SB, Meis JF, de Hoog ...
  • Taj-Aldeen SJ. Reduced multidrug susceptibility profile is a common feature ...
  • de Hoog GS, Guarro J, Gené J, Figueras MJ. Atlas ...
  • van Diepeningen AD, Feng P, Ahmed S, Sudhadham M, Bunyaratavej ...
  • Davari M, Wei SH, Babay-Ahari A, Arzanlou M, Waalwijk C, ...
  • Clinical and Laboratory Standards Institute. Reference method for broth dilution ...
  • Indian Council of Medical Research (ICMR). Ethical guidelines for biomedical ...
  • World Medical Association Declaration of Helsinki. Ethical principles for medical ...
  • Herkert PF, Al-Hatmi AMS, de Oliveira Salvador GL, Muro MD, ...
  • Tortorano AM, Prigitano A, Esposto MC, Arsic Arsenijevic V, Kolarovic ...
  • Bansal Y, Chander J, Kaistha N, Singla N, Sood S, ...
  • Tosti A, Elewski BE. Onychomycosis: practical approaches to minimize relapse ...
  • Diongue K, Ndiaye M, Seck MC, Diallo MA, Badiane AS, ...
  • Ranawaka RR, Nagahawatte A, Gunasekara TA. Fusarium onychomycosis: prevalence, clinical ...
  • Esnakula AK, Summers I, Naab TJ. Fatal disseminated fusarium infection ...
  • Marom EM, Holmes AM, Bruzzi JF, Truong MT, O'Sullivan PJ, ...
  • Tortorano AM, Richardson M, Roilides E, van Diepeningen A, Caira ...
  • Nucci M, Marr KA, Vehreschild MJ, de Souza CA, Velasco ...
  • Al-Hatmi AMS, Bonifaz A, Ranque S, de Hoog GS, Verweij ...
  • نمایش کامل مراجع